261Y000008- CPA 2023/0495 - Medications for the Genitourinary System
About This Opportunity
TranslatedThis tender, identified as 261Y000008- CPA 2023/0495, pertains to the procurement of medications specifically for the genitourinary system. The aim of this tender is to acquire pharmaceutical products that are essential for the treatment and management of conditions affecting the genitourinary tract. Key requirements for bidders may include the provision of high-quality medications that meet regulatory standards, as well as the ability to deliver these products within specified timelines. It is crucial for participating vendors to demonstrate compliance with relevant health regulations and to provide evidence of their capability to supply the required medications consistently. The tender is likely to be relevant to public health sectors, including hospitals and clinics that require these medications for patient care. Interested parties should ensure they are familiar with the specific terms and conditions outlined in the tender documents, including submission deadlines and evaluation criteria. This procurement process is part of a broader initiative to enhance healthcare services and ensure the availability of necessary treatments for patients suffering from genitourinary disorders. The location of the tender is not explicitly stated, but it is assumed to be within the jurisdiction of the issuing authority.
This is a supplies contract in the health and medical services, information and communication technology and trade and industry sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,441.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified as 261Y000008- CPA 2023/0495, pertains to the procurement of pharmaceuticals specifically for the genitourinary system. It is being issued in Portugal, reflecting the country’s ongoing efforts to enhance its healthcare provisions through the acquisition of essential medical supplies. The contracting authority overseeing this tender is likely a governmental health entity, although specifics are not detailed in the provided information.
The procurement is aimed at securing a range of medications that are critical for the treatment and management of conditions affecting the genitourinary system. These medications are essential for various therapeutic applications, including but not limited to, urological disorders, reproductive health issues, and related complications.
Typical requirements for tenders of this nature usually include compliance with national and international pharmaceutical regulations, quality assurance protocols, and evidence of previous successful deliveries in similar contracts. Bidder qualifications may necessitate the provision of documentation demonstrating relevant certifications, including Good Manufacturing Practice (GMP) compliance, as well as the ability to supply a sustainable and uninterrupted flow of products.
Potential bidders are encouraged to familiarize themselves with the specific needs outlined in the tender documents and prepare comprehensive proposals that address all technical and financial criteria. This tender represents an opportunity for pharmaceutical companies to contribute to the healthcare system in Portugal, ensuring that patients have access to necessary medications for their health and well-being.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 11, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Santa Maria, EPE
Unidade Local de Saúde de Santa Maria, EPE has issued 1,082 procurement notices on BidsFactory, including 6 currently open and 920 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Transport & Logistics. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to ASTELLAS FARMA, LDA.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Santa Maria, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €1,441. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.